	Leisure-time physical activity, sun exposure, and multiple sclerosis risk: a population-based case-control study. J Neurol Guo Q, Olsson T, Alfredsson L, Hedström AK. PMID: 42799788 [PubMed - indexed for MEDLINE]
	Reframing the Gut-Brain Axis: The Gut Wall as a Neural Immune Interface in Multiple Sclerosis and Autoimmune Neurological Diseases. Ann Neurol Montini F, Pittock SJ, Cacciaguerra L, Weiner HL, Schwerdtfeger LA. PMID: 42799661 [PubMed - as supplied by publisher]
	Disabilities and Health-Related Quality of Life in Multiple Sclerosis: Prospective 10-year Web-Based Study of a Population-Based Real-Life Cohort in the Netherlands. Degener Neurol Neuromuscul Dis Jongen PJ, Yaylali A, Kremer IEH, Heerings M, van Noort E, van Dijk JP, Brandts L, van Mastrigt G. PMID: 42799509 [PubMed]
	Correction: Efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials with clinical implications for patient stratification and treatment optimization. Front Immunol Guo H, Zeng L, Sun L. PMID: 42798841 [PubMed - in process]
	Eating-Related Profiles in Multiple Sclerosis: Associations with Coping, Health Locus of Control, and Self-Management. Nutrients Wilski M, Gabryelski J, Brola W. PMID: 42796967 [PubMed - indexed for MEDLINE]
	Longitudinal Visual Evoked Potential Changes Show Distinct Associations with Relapse Activity and Disability in Relapsing-Remitting Multiple Sclerosis: A Multicenter Retrospective Cohort Study. Medicina (Kaunas) Öncel S, Sefero, Ömerhoca S, Aksu S, Ç, K, Tunç A, . PMID: 42796356 [PubMed - indexed for MEDLINE]
	Clinical Impact of Fingolimod-Associated Lymphopenia in Multiple Sclerosis: A Real-World Cohort Study. Medicina (Kaunas) Yeniçeri M, , Ba, Çoban HH, Gürbüz Yeniçeri A, Demir S, Tanoglu A. PMID: 42796323 [PubMed - indexed for MEDLINE]
	Longitudinal Stability of the Gut Microbiota in Relapsing-Remitting Multiple Sclerosis: A Prospective Observational Study. Microorganisms Vacaras C, Vacaras V, Nistor C, Jucan C, Furdui IM, Vesa SC, Strilciuc S, , Chira D, Rafila A, Muresanu DF. PMID: 42795661 [PubMed]
	Selected Cytokines and Matrix Metalloproteinases in Pathogenesis and Treatment of Multiple Sclerosis. Int J Mol Sci Mroczko J, Romanowicz A, , Mroczko B, Kulczy, Glodzik L. PMID: 42794509 [PubMed - indexed for MEDLINE]
	CAR-T Cell Therapy and Gut Microbiota Modulation in Multiple Sclerosis: Emerging Therapeutic Strategies and Current Limitations. Curr Issues Mol Biol Chasov V, Mukhametshin S, Valiullina A, Skibo Y, Zhumabekova M, Zharlyganova D, Keyer V, Kydyrbayeva A, Shustov A, Bulatov E. PMID: 42793314 [PubMed]
	Hippocampal Radiomic Signatures in Multiple Sclerosis Subtypes: A Machine Learning-Based MRI Study. J Imaging Inform Med Tekeli M, Cezayirli E, Çevik Y, Kiliç N, Dik B, Yücel S, Tekeli R, Balal M, Kaya Ö, Erdem H, Boyan N, O. PMID: 42791470 [PubMed - as supplied by publisher]
	Difficult relationships between humans and bacteria: associations between multiple sclerosis and the human microbiome. Antonie Van Leeuwenhoek Dul, Sabat Z, Kukla I, Szcze, Jasi, Adamus-Bia. PMID: 42791381 [PubMed - indexed for MEDLINE]
	Targeting the Î±7-nicotinic acetylcholine receptor in multiple sclerosis: Implications for immunomodulation and neuroprotection. Life Sci Al-Dhahi AS, Al-Kuraishy HM, Mohamed AA, Salama MM, Alanazi YS, Fawzy MN, Batiha GE. PMID: 42790772 [PubMed - as supplied by publisher]
	A Brief emotion-focused psychodynamic intervention for fatigue, pain, and health-related quality of life in women with relapsing-remitting multiple sclerosis: A randomized pilot trial. Mult Scler Relat Disord Rahnama Z, Momeni A, Amirazodi Z, Hosseini H. PMID: 42790154 [PubMed - as supplied by publisher]
	Recognition and Treatment of Concurrent Amyotrophic Lateral Sclerosis and Multiple Sclerosis. R I Med J (2013) Eng NY, Rizvi S, LaBarbera V. PMID: 42789802 [PubMed - indexed for MEDLINE]
	Strategies for integrating artificial intelligence and cognitive assessment to predict disability progression in relapsing-remitting multiple sclerosis: A model development study. PLOS Digit Health Zhu C, Zhang X, van der Walt A, Taylor B, Monif M, Kalincik T, Lechner-Scott J, Buzzard K, Kilpatrick T, Barnett M, Zhou Z, Jokubaitis V, Gresle M, Darby D, Mehta D, Ge Z, Butzkueven H, Merlo D. PMID: 42789556 [PubMed]
	Effectiveness of a self-management educational program among people with multiple sclerosis: a pre-test post-test intervention study. J Egypt Public Health Assoc Elnaggar F, Fetohy EM, Shata ZN, Hamdy E. PMID: 42789209 [PubMed]
	Exploring work stressors and resources and their perceived effects on symptoms and work ability in employees with multiple sclerosis: a qualitative study. BMC Neurol Bau JT, Guthardt L, Apolinário-Hagen J, Loerbroks A, Meuth SG, Weber J. PMID: 42786464 [PubMed - indexed for MEDLINE]
	Anti-CD20 monoclonal antibody therapies in relapsing multiple sclerosis: A systematic review and meta-analysis of randomised controlled trials. Mult Scler Relat Disord Alatawi A, Al-Dhahi AS, Alatawi A, Almaser S. PMID: 42785004 [PubMed - as supplied by publisher]
	Generative AI responses to exercise-related questions asked by patients with multiple sclerosis: An evaluation of quality, accuracy, and readability. Mult Scler Relat Disord Delibay AA, Demir CO, Turutgen N, Kiloatar H, Donmez S. PMID: 42785003 [PubMed - as supplied by publisher]

Articles 1 - 20 / 44952

Page 1 of 2248



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy